Page 70 - Petelin, Ana, Nejc Šarabon, Boštjan Žvanut, eds. 2017. Zdravje delovno aktivne populacije ▪︎ Health of the Working-Age Population. Proceedings. Koper: Založba Univerze na Primorskem/University of Primorska Press
P. 70
avje delovno aktivne populacije | health of the working-age population 68 long-term weight loss: a meta-analysis of randomised controlled trials.
The British Journal of Nutrition, vol. 110, no. 7, pp. 1178-1187.
CAHILL, G.F., Jr. 2006. Fuel metabolism in starvation. Annual Review of Nutri-
tion, vol. 26, pp. 1-22.
CASTELLANO, C. et al. 2015. Lower brain 18F-fluorodeoxyglucose uptake but
normal 11C-acetoacetate metabolism in mild Alzheimer‘s disease demen-
tia. Journal of Alzheimer‘s Disease, vol. 43, no. 4, pp. 1343-1353.
CHANG, C.K., BORER, K. and LIN, P.J. 2017. Low-Carbohydrate-High-Fat Di-
et: Can it Help Exercise Performance? Journal of Human Kinetics, vol. 56,
pp. 81-92.
COSTANTINI, L.C., BARR, L.J., VOGEL, J.L. and HENDERSON, S.T. 2008.
Hypometabolism as a therapeutic target in Alzheimer‘s disease. BMC
Neuroscience, vol. 9 Suppl 2, pp. S16.
CURRAIS, A. 2015. Ageing and inflammation - A central role for mitochondria
in brain health and disease. Ageing Research Reviews, vol. 21, pp. 30-42.
DE LA MONTE, S.M. and WANDS, J.R. 2008. Alzheimer‘s Disease is Type 3
Diabetes—Evidence Reviewed. Journal of Diabetes Science and Technology,
vol. 2, no. 6, pp. 1101-1113.
DE LEON, M.J. et al. 1983. Positron emission tomographic studies of aging and
Alzheimer disease. AJNR. American Journal of Neuroradiology, vol. 4.
ERICKSON, N., BOSCHERI, A., LINKE, B. and HUEBNER, J. 2017. Systemat-
ic review: isocaloric ketogenic dietary regimes for cancer patients. Medi-
cal Oncology, vol. 34, no. 5, pp. 72.
FARIAS, G.A., GUZMÁN-MARTÍNEZ, L., DELGADO, C. and MACCIONI,
R.B. 2014. Nutraceuticals: a novel concept in prevention and treatment of
Alzheimer‘s disease and related disorders. Journal of Alzheimer‘s Disease,
vol. 42, no. 2, pp. 357-367.
FERNANDO, W.M. et al. 2015. The role of dietary coconut for the prevention
and treatment of Alzheimer‘s disease: potential mechanisms of action.
The British Journal of Nutrition, vol. 114, no. 1, pp. 1-14.
GANO, L.B., PATEL, M. and RHO, J.M. 2014. Ketogenic diets, mitochondria,
and neurological diseases. Journal of Lipid Research, vol. 55, no. 11, pp. 2211-
2228.
GROM, G. 2016. Koristi ketogene diete za starejše: sindromi demence in
Alzheimerjeva bolezen. Živeti življenje v varni starosti : zbornik pre-
davanj, 2. Kongres gerontološke zdravstvene nege in oskrbe, Portorož,
Strokovna sekcija medicinskih sester in zdravstvenih tehnikov v social-
nih zavodih, Ljubljana.
HARTMAN, A.L. 2012. Neuroprotection in metabolism-based therapy. Epilep-
sy Research, vol. 100, no. 3, pp. 286-294.
HERTZ, L., CHEN, Y. and WAAGEPETERSEN, H.S. 2015. Effects of ketone
bodies in Alzheimer‘s disease in relation to neural hypometabolism, be-
The British Journal of Nutrition, vol. 110, no. 7, pp. 1178-1187.
CAHILL, G.F., Jr. 2006. Fuel metabolism in starvation. Annual Review of Nutri-
tion, vol. 26, pp. 1-22.
CASTELLANO, C. et al. 2015. Lower brain 18F-fluorodeoxyglucose uptake but
normal 11C-acetoacetate metabolism in mild Alzheimer‘s disease demen-
tia. Journal of Alzheimer‘s Disease, vol. 43, no. 4, pp. 1343-1353.
CHANG, C.K., BORER, K. and LIN, P.J. 2017. Low-Carbohydrate-High-Fat Di-
et: Can it Help Exercise Performance? Journal of Human Kinetics, vol. 56,
pp. 81-92.
COSTANTINI, L.C., BARR, L.J., VOGEL, J.L. and HENDERSON, S.T. 2008.
Hypometabolism as a therapeutic target in Alzheimer‘s disease. BMC
Neuroscience, vol. 9 Suppl 2, pp. S16.
CURRAIS, A. 2015. Ageing and inflammation - A central role for mitochondria
in brain health and disease. Ageing Research Reviews, vol. 21, pp. 30-42.
DE LA MONTE, S.M. and WANDS, J.R. 2008. Alzheimer‘s Disease is Type 3
Diabetes—Evidence Reviewed. Journal of Diabetes Science and Technology,
vol. 2, no. 6, pp. 1101-1113.
DE LEON, M.J. et al. 1983. Positron emission tomographic studies of aging and
Alzheimer disease. AJNR. American Journal of Neuroradiology, vol. 4.
ERICKSON, N., BOSCHERI, A., LINKE, B. and HUEBNER, J. 2017. Systemat-
ic review: isocaloric ketogenic dietary regimes for cancer patients. Medi-
cal Oncology, vol. 34, no. 5, pp. 72.
FARIAS, G.A., GUZMÁN-MARTÍNEZ, L., DELGADO, C. and MACCIONI,
R.B. 2014. Nutraceuticals: a novel concept in prevention and treatment of
Alzheimer‘s disease and related disorders. Journal of Alzheimer‘s Disease,
vol. 42, no. 2, pp. 357-367.
FERNANDO, W.M. et al. 2015. The role of dietary coconut for the prevention
and treatment of Alzheimer‘s disease: potential mechanisms of action.
The British Journal of Nutrition, vol. 114, no. 1, pp. 1-14.
GANO, L.B., PATEL, M. and RHO, J.M. 2014. Ketogenic diets, mitochondria,
and neurological diseases. Journal of Lipid Research, vol. 55, no. 11, pp. 2211-
2228.
GROM, G. 2016. Koristi ketogene diete za starejše: sindromi demence in
Alzheimerjeva bolezen. Živeti življenje v varni starosti : zbornik pre-
davanj, 2. Kongres gerontološke zdravstvene nege in oskrbe, Portorož,
Strokovna sekcija medicinskih sester in zdravstvenih tehnikov v social-
nih zavodih, Ljubljana.
HARTMAN, A.L. 2012. Neuroprotection in metabolism-based therapy. Epilep-
sy Research, vol. 100, no. 3, pp. 286-294.
HERTZ, L., CHEN, Y. and WAAGEPETERSEN, H.S. 2015. Effects of ketone
bodies in Alzheimer‘s disease in relation to neural hypometabolism, be-
